Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Baxter
Boehringer Ingelheim
Farmers Insurance
Colorcon
Healthtrust
UBS
Queensland Health
Merck
Johnson and Johnson

Generated: August 18, 2017

DrugPatentWatch Database Preview

Phentolamine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phentolamine mesylate and what is the scope of phentolamine mesylate patent protection?

Phentolamine mesylate
is the generic ingredient in three branded drugs marketed by West-ward Pharms Int, Septodont Holding, and Novartis, and is included in three NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Phentolamine mesylate has thirty patent family members in twenty countries.

There are four drug master file entries for phentolamine mesylate. Two suppliers are listed for this compound.

Summary for Generic Name: phentolamine mesylate

Tradenames:3
Patents:5
Applicants:3
NDAs:3
Drug Master File Entries: see list4
Suppliers / Packagers: see list2
Bulk Api Vendors: see list53
Clinical Trials: see list520
Patent Applications: see list1,113
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phentolamine mesylate at DailyMed

Pharmacology for Ingredient: phentolamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Septodont Holding
ORAVERSE
phentolamine mesylate
INJECTABLE;INJECTION022159-001May 9, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Septodont Holding
ORAVERSE
phentolamine mesylate
INJECTABLE;INJECTION022159-001May 9, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Septodont Holding
ORAVERSE
phentolamine mesylate
INJECTABLE;INJECTION022159-001May 9, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
Septodont Holding
ORAVERSE
phentolamine mesylate
INJECTABLE;INJECTION022159-001May 9, 2008RXYesYes► Subscribe► Subscribe► Subscribe
Septodont Holding
ORAVERSE
phentolamine mesylate
INJECTABLE;INJECTION022159-001May 9, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: phentolamine mesylate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,432,401 Local anesthetic methods and kits► Subscribe
7,261,889Local anesthetic methods and kits► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: phentolamine mesylate

Country Document Number Estimated Expiration
China1688312► Subscribe
Australia2001259848► Subscribe
Denmark1280531► Subscribe
Japan2010280702► Subscribe
Hong Kong1079444► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Teva
Chinese Patent Office
Cipla
McKesson
Mallinckrodt
Queensland Health
Dow
Colorcon
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot